-
Published 9/21/2018
Tang SC, Yang KC, Chen CH, Yang SY, Chiu MJ, Wu CC, Jeng JS. Plasma ß-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment. Neuromolecular Med. 2018 Dec; 20(4):498-503. PMID: 30242618.
-
Published 8/16/2018
Yang S, Leone DA, Biswas A, Deng A, Jukic D, Singh R, Sundram U, Mahalingam M. Concordance of somatic mutation profiles (BRAF,NRAS, and TERT) and tumoral PD-L1 in matched primary cutaneous and metastatic melanoma samples. Hum Pathol. 2018 12; 82:206-214. PMID: 30120967.
-
Published 7/3/2018
de la Cueva A, Emmerling M, Lim SL, Yang S, Trackman PC, Sonenshein GE, Kirsch KH. A polymorphism in the lysyl oxidase propeptide domain accelerates carcinogen-induced cancer. Carcinogenesis. 2018 07 03; 39(7):921-930. PMID: 29579155.
-
Published 5/6/2018
Alekseyev YO, Fazeli R, Yang S, Basran R, Maher T, Miller NS, Remick D. A Next-Generation Sequencing Primer-How Does It Work and What Can It Do? Acad Pathol. 2018 Jan-Dec; 5:2374289518766521. PMID: 29761157.
-
Published 1/13/2017
Frydenlund N, Leone D, Yang S, Hoang MP, Deng A, Hernandez-Perez M, Singh R, Biswas A, Yaar R, Mahalingam M. Tumoral PD-L1 expression in desmoplastic melanoma is associated with depth of invasion, tumor-infiltrating CD8 cytotoxic lymphocytes and the mixed cytomorphological variant. Mod Pathol. 2017 Mar; 30(3):357-369. PMID: 28084337.